The ongoing clinical trial MeRT-TBI-005, conducted in collaboration with SOCOM and the Department of Defense, is at the forefront of evaluating the safety and efficacy of Magnetic e-Resonance Therapy (MeRT™) for treating Persistent Post-Concussive Symptoms (PPCS). This innovative study aims to assess how well MeRT™, a cutting-edge technology that leverages computational neuroanalytics and brain imaging, can address the lingering effects of traumatic brain injuries, including cognitive impairments and emotional disturbances. By focusing on the unique needs of service members, this trial represents a significant step toward finding effective, non-invasive solutions for the complex challenges faced by veterans with PPCS.
